NDC 64380-712 – Benzonatate
Benzonatate 100 mg/1 · Capsule · Oral
Product NDC64380-712
Product details
- Brand name
- Benzonatate
- Generic name
- Benzonatate
- Labeler
- Strides Pharma Science Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA091133
- Marketed since
- May 29, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Non-narcotic Antitussive
Active ingredients
- Benzonatate 100 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 64380-712-06 | 100 CAPSULE in 1 CONTAINER (64380-712-06) | May 29, 2026 |
| 64380-712-07 | 500 CAPSULE in 1 BOTTLE (64380-712-07) | May 29, 2026 |
Recalls mentioning this NDC
- D-0858-2017 May 31, 2017 · Class III
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Other Benzonatate products
- 50090-6080 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6294 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6850 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6387 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4968 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4969 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5409 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5986 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 68084-214 Benzonatate 100 mg/1 · Capsule · American Health Packaging
- 87519-111 Benzonatate 150 mg/1 · Capsule · Anvi Pharmaceuticals Inc
- 71610-692 Benzonatate 100 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-573 Benzonatate 100 mg/1 · Capsule · Ascend Laboratories, LLC